Literature DB >> 16574927

Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia.

Cinzia Costa1, Giuseppina Martella, Barbara Picconi, Chiara Prosperetti, Antonio Pisani, Massimiliano Di Filippo, Francesco Pisani, Giorgio Bernardi, Paolo Calabresi.   

Abstract

BACKGROUND AND
PURPOSE: The possible neuroprotective effects of classic and new antiepileptic drugs on the electrophysiological changes induced by in vitro ischemia on striatal neurons were investigated. In particular, the aim of the study was to correlate the putative neuroprotective effects with the action of these drugs on fast sodium (Na+) and high-voltage-activated (HVA) calcium (Ca2+) currents.
METHODS: Extracellular field potentials were recorded from rat corticostriatal brain-slice preparations. In vitro ischemia was delivered by switching to an artificial cerebrospinal fluid solution in which glucose and oxygen were omitted. Na+ and HVA Ca2+ currents were analyzed by whole-cell patch-clamp recordings from acutely isolated rat striatal neurons. Excitatory postsynaptic potential was measured following synaptic stimulation in corticostriatal slices by sharp intracellular microelectrodes.
RESULTS: Neuroprotection against in vitro ischemia was observed in slices treated with carbamazepine (CBZ), valproic acid (VPA), and topiramate (TPM), whereas it was not achieved by using levetiracetam (LEV). Fast Na+ conductances were inhibited by CBZ and TPM, whereas VPA and LEV showed no effect. HVA Ca2+ conductances were reduced by CBZ, TPM, and LEV. VPA had no effect on this current. All antiepileptic drugs induced a small reduction of excitatory postsynaptic potential amplitude at concentrations higher than 100 microm without changes of paired-pulse facilitation.
CONCLUSIONS: The concomitant inhibition of fast Na+ and HVA Ca2+ conductances is critically important for the neuroprotection, whereas the presynaptic inhibition on glutamate transmission does not seem to play a major role.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574927     DOI: 10.1161/01.STR.0000217303.22856.38

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  26 in total

Review 1.  Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

Authors:  D Caccamo; L R Pisani; P Mazzocchetti; R Ientile; P Calabresi; F Pisani; C Costa
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

2.  New treatment options in status epilepticus: a critical review on intravenous levetiracetam.

Authors:  Eugen Trinka; Judith Dobesberger
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

3.  Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

Authors:  Rainer Surges; Kirill E Volynski; Matthew C Walker
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

4.  Small molecule anticonvulsant agents with potent in vitro neuroprotection.

Authors:  Douglas E Brenneman; Garry R Smith; Yan Zhang; Yanming Du; Sandeep K Kondaveeti; Michael J Zdilla; Allen B Reitz
Journal:  J Mol Neurosci       Date:  2012-04-26       Impact factor: 3.444

Review 5.  Synergistic neuroprotective therapies with hypothermia.

Authors:  Maria Roberta Cilio; Donna M Ferriero
Journal:  Semin Fetal Neonatal Med       Date:  2010-03-07       Impact factor: 3.926

6.  Ischemic stroke injury is mediated by aberrant Cdk5.

Authors:  Douglas A Meyer; Melissa I Torres-Altoro; Zhenjun Tan; Alessandro Tozzi; Massimiliano Di Filippo; Vincent DiNapoli; Florian Plattner; Janice W Kansy; Stanley A Benkovic; Jason D Huber; Diane B Miller; Paul Greengard; Paolo Calabresi; Charles L Rosen; James A Bibb
Journal:  J Neurosci       Date:  2014-06-11       Impact factor: 6.167

7.  Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats.

Authors:  Mustafa Komur; Cetin Okuyaz; Yalcin Celik; Bora Resitoglu; Ayse Polat; Senay Balci; Lulufer Tamer; Semra Erdogan; Huseyin Beydagi
Journal:  Childs Nerv Syst       Date:  2014-02-14       Impact factor: 1.475

Review 8.  Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

Authors:  Cecilie Johannessen Landmark
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes.

Authors:  Sara Sanz-Blasco; Juan C Piña-Crespo; Xiaofei Zhang; Scott R McKercher; Stuart A Lipton
Journal:  Neuroreport       Date:  2016-06-15       Impact factor: 1.837

10.  Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration.

Authors:  K-K Tai; N Nguyen; L Pham; D D Truong
Journal:  J Neural Transm (Vienna)       Date:  2008-05-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.